From Science and Technology to Eye-Health Policy: A Review on Global and Asia–Pacific Strategies on the Prevention of Blindness from Retinal Diseases

The World Health Organization (WHO) is making a concerted effort to enhance health, including eye health and overall well-being. This global effort has resulted in a reduced age-standardized prevalence of avoidable blindness and no increase in avoidable moderate and severe vision impairment. However, the absolute number of cases has increased for both avoidable blindness and moderate-to-severe vision impairment. Globally, the leading causes of visual impairment include uncorrected refractive errors and cataract, though many retinal conditions equally contribute. All causes of blindness and moderate-to-severe visual impairment are higher in low- and middle-income countries, including many in the Asia-Pacific region. This inequality could be reduced by harmonizing science and technology and translating them into regulatory policy to close the care loop.This review aimed to provide a perspective on the disease burden of common retinal conditions such as diabetic retinopathy, age-related macular degeneration, myopia, and retinopathy of prematurity; the latest science and technology for diagnosing and treating these conditions; and recommendations to translate them into national policy. We also reviewed the WHO's global policy and targets related to the United Nations Sustainable Development Goals, recommended to prevent global blindness by the year 2030. The national health and eye care systems, from primary to tertiary care, in an Asia-Pacific country, which align with "Integrated People-Centered Eye Care" proposed by WHO, are also reviewed.

Authors

Institutions

Publication Details

Journal
Ophthalmology and Therapy
Published
2026-03-16
DOI
https://doi.org/10.1007/s40123-026-01361-w
Primary Topic
Ophthalmology and Visual Impairment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

From Science and Technology to Eye-Health Policy: A Review on Global and Asia–Pacific Strategies on the Prevention of Blindness from Retinal Diseases

T. P. Das, A. L. C. TAN, Seang Mei Saw, Jost Jonas et al.
Ophthalmology and Therapy
Ophthalmology and Visual Impairment Studies
article

From Science and Technology to Eye-Health Policy: A Review on Global and Asia–Pacific Strategies on the Prevention of Blindness from Retinal Diseases

T. P. Das, A. L. C. TAN, Seang Mei Saw, Jost Jonas, Sobha Sivaprasad, Paisan Ruamviboonsuk, Ryo Kawasaki, Subhadra Jalali
article en

Abstract

The World Health Organization (WHO) is making a concerted effort to enhance health, including eye health and overall well-being. This global effort has resulted in a reduced age-standardized prevalence of avoidable blindness and no increase in avoidable moderate and severe vision impairment. However, the absolute number of cases has increased for both avoidable blindness and moderate-to-severe vision impairment. Globally, the leading causes of visual impairment include uncorrected refractive errors and cataract, though many retinal conditions equally contribute. All causes of blindness and moderate-to-severe visual impairment are higher in low- and middle-income countries, including many in the Asia-Pacific region. This inequality could be reduced by harmonizing science and technology and translating them into regulatory policy to close the care loop.This review aimed to provide a perspective on the disease burden of common retinal conditions such as diabetic retinopathy, age-related macular degeneration, myopia, and retinopathy of prematurity; the latest science and technology for diagnosing and treating these conditions; and recommendations to translate them into national policy. We also reviewed the WHO's global policy and targets related to the United Nations Sustainable Development Goals, recommended to prevent global blindness by the year 2030. The national health and eye care systems, from primary to tertiary care, in an Asia-Pacific country, which align with "Integrated People-Centered Eye Care" proposed by WHO, are also reviewed.

Ophthalmology and Therapy
University of Jos (NG), Chinese University of Hong Kong (HK), Institut Français (FR), Singapore National Eye Center (SG), New York Eye and Ear Infirmary (US), L V Prasad Eye Institute (IN), Aditya Jyot Eye Hospital (IN), NIHR Moorfields Biomedical Research Centre (GB), Osaka Health Science University (JP), Rajavithi Hospital (TH), Singapore Eye Research Institute (SG), Duke-NUS Medical School (SG), Fondation de Rothschild (FR), Moorfields Eye Hospital (GB), Beijing Tsinghua Chang Gung Hospital (CN), Osaka University Hospital (JP), University College London (GB), Rangsit University (TH), Icahn School of Medicine at Mount Sinai (US)
Openalex Percentile: Top 22%
Ophthalmology and Visual Impairment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.